Oruka Therapeutics, Inc. — insider transactions
8 transactions on record · ORKA · CIK 907654
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
8
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$1M
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$480.2K
2026-07-13
Director share, 12m
0.0%
of transactions where role is stated
Current run
8 sells
consecutive same-direction transactions
Net 3m flow
-$1M
purchases minus sales
Total on record
8
Transactions
8 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-13 | 2026-07-13 | 0 | Agarwal Arjun | Senior Vice President, Finance | Exercise of derivative | 1,458 | $34.39 | $50.1K | filing |
| 2026-07-13 | 2026-07-13 | 0 | Agarwal Arjun | Senior Vice President, Finance | Open market sale | 5,656 | $84.90 | $480.2K | filing |
| 2026-07-13 | 2026-07-13 | 0 | Agarwal Arjun | Senior Vice President, Finance | Exercise of derivative | 1,458 | $0.00 | — | filing |
| 2026-07-13 | 2026-07-13 | 0 | Agarwal Arjun | Senior Vice President, Finance | Exercise of derivative | 8,541 | $12.50 | $106.8K | filing |
| 2026-07-13 | 2026-07-13 | 0 | Agarwal Arjun | Senior Vice President, Finance | Open market sale | 3,743 | $84.26 | $315.4K | filing |
| 2026-07-13 | 2026-07-13 | 0 | Agarwal Arjun | Senior Vice President, Finance | Exercise of derivative | 8,541 | $0.00 | — | filing |
| 2026-07-13 | 2026-07-13 | 0 | Agarwal Arjun | Senior Vice President, Finance | Open market sale | 300 | $83.07 | $24.9K | filing |
| 2026-07-13 | 2026-07-13 | 0 | Agarwal Arjun | Senior Vice President, Finance | Open market sale | 300 | $85.63 | $25.7K | filing |